Authors: HOLM PS GOLDMAN CK DIETEL M CURIEL DT

Citation: Ps. Holm et al., INHIBITION OF THE MULTIDRUG-RESISTANCE PHENOTYPE BY ADENOVIRAL DELIVERY OF AN ANTI-MDR RIBOZYME, Cancer gene therapy, 4(5), 1997, pp. 305-305

Authors: BOUFFARD DY OHKAWA T KIJIMA H IRIE A SUZUKI T CURCIO LD HOLM PS SASSANI A SCANLON KJ

Citation: Dy. Bouffard et al., OLIGONUCLEOTIDE MODULATION OF MULTIDRUG-RESISTANCE, European journal of cancer, 32A(6), 1996, pp. 1010-1018

Authors: DIETEL M HOLM PS GOLDMAN CK CURIEL D

Citation: M. Dietel et al., ADENOVIRAL TRANSFER OF AN ANTI-MDR1 RIBOZYME TO REVERSE THE MULTIDRUG-RESISTANT PHENOTYPE, Cancer gene therapy, 3(6), 1996, pp. 92-92

Authors: HOLM PS DIETEL M KRUPP G

Citation: Ps. Holm et al., SIMILAR CLEAVAGE EFFICIENCIES OF AN OLIGORIBONUCLEOTIDE SUBSTRATE ANDAN MDR1 MESSENGER-RNA SEGMENT BY A HAMMERHEAD RIBOZYME, Gene, 167(1-2), 1995, pp. 221-225

Authors: HOLM PS SCANLON KJ DIETEL M

Citation: Ps. Holm et al., REVERSION OF MULTIDRUG-RESISTANCE IN THE P-GLYCOPROTEIN-POSITIVE HUMAN PANCREATIC-CELL LINE (EPP85-181RDB) BY INTRODUCTION OF A HAMMERHEAD RIBOZYME, British Journal of Cancer, 70(2), 1994, pp. 239-243